TMTYB S01E10 (Board Effectiveness) This is Take Me To Your Board from the Tasmanian Council of Social Service. This show's about governance, and it's not just for aspiring or current board members. It's for anyone who wants to hear from some of the country's top leaders about how a good board really should work. Each episode's based on one of the 10 principles of not-for-profit governance as laid out by the Australian Institute of Company Directors, hosted by Bridget Delaney and Cameron Allen. Bridget Delaney: Today, I'd like to discuss principle number four, board effectiveness. The AICD breakdown board effectiveness by way of the internal process of the board. They stipulate that for a board to be effective, it must take a thoughtful, disciplined and professional approach to its work. This includes forward planning, efficient operation of meetings and performance assessments. This principal brings to life what a board does functionally, and by extension, what role each board member plays in that responsibility. This principle is less conceptual than many others. It feels almost like a checklist for your board and how it should run. Cameron Allen: It's good to have that clarity and delineation around what are key roles in upholding good governance of an organisation. Bridget Delaney: Indeed it is. But I must admit this made the task of finding an example of where things go awry somewhat difficult. Openly saying where your process falls down, for example, where a chair is ineffective and performance assessments have been neglected, it's hard to recognise and is often the path that leads to multiple other issues. I guess like all principles, it weaves in and out of all of our other examples. However, as always, I have found something worth exploring. This company we will look at today is Theranos. Apart from being a very fun word to say, Theranos is a Silicon Valley start-up in the medical technology industry that claimed to have created blood tests that required very little blood, but performed rapid analysis. It was founded in 2003 by 19-year-old Elizabeth Holmes. It gained investments exceeding $700 million from private investors. And by 2014, she presided over a company worth $10 billion, with Holmes quickly ascending the charts to become one of the richest self-made women in the world. In 2012, the partnership started to hustle in. Investments from companies like Pfizer, Safeway and Cleveland Clinic followed, all wanting to get in on the technology that would reduce their costs and resourcing and increase their productivity. By 2015, Theranos received the Bioscience Company of the Year by the Arizona Bioindustry Association. Cameron Allen: Sounds pretty much like the Silicon Valley we all understand and have come to know. Bridget Delaney:
TMTYB S01E10 Board Effectiveness Transcript by Rev.com
Page 1 of 13